Study KC1036 for advanced thymus tumors after chemotherapy
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests KC1036 in people with advanced thymoma or thymic carcinoma whose cancer came back or spread after their first standard chemotherapy. It may offer a new treatment option when earlier treatment no longer worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed thymoma or thymic carcinoma (a thymus tumor), based on lab exam of tissue cells
- Your cancer is advanced and cannot be fully removed by surgery (recurrent, unresectable, and/or metastatic)
- Your cancer returned after first-line chemotherapy
- You have at least one measurable tumor spot that can be tracked on scans
- Your general health is good enough (ECOG performance status 0 or 1), and you can expect to live more than 12 weeks
- Your organs (kidneys, liver, blood counts) are healthy enough for treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
This trial tests whether 6 cycles of chemotherapy before surgery works better than 3 cycles for people with advanced thymus gland tumors that can be surgically removed. It aims to improve treatment outcomes for locally advanced thymoma or thymic carcinoma.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial tests a new drug, sacituzumab tirumotecan, in people with advanced thymic carcinoma that has spread or cannot be removed with surgery. It is for those whose cancer has gotten worse after at least one round of platinum-based chemotherapy.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
Hear when a new Thymic Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.